BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by dateSort by citations
Year Range
to
Clear all filters

All Papers

16+ results
Field: SARS-CoV-2 and COVID-19 Research

COVID-19 and the cardiovascular system

Verified

Ying‐Ying Zheng, Yi‐Tong Ma, Jinying Zhang, Xiang Xie

Journal: Nature Reviews Cardiology 2020
Year:
Citations: 3061

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through ACE2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, while also causing acute myocardial injury and chronic damage to the cardiovascular system. Therefore, particular attention should be g...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines

Verified

Yusha Araf, F. Akter, Yan‐Dong Tang, Rabeya Fatemi et al.

Journal: Journal of Medical VirologyYear: 2022Citations: 909

Currently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide as an Omicron variant. This variant is a heavily mutated virus and designated as a variant of concern by the World Health Organization (WHO). WHO cautioned that the Omicron variant of SARS-CoV-2 held a very ...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study

Verified

Elaine Robertson, Kelly S Reeve, Claire L. Niedzwiedz, Jamie Moore et al.

Journal: Brain Behavior and ImmunityYear: 2021Citations: 719

Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine hesitant subgroups. The 'Understanding Society' COVID-19 survey asked participants (n = 12,035) their likelihood of vaccine uptake and reason f...

Social SciencesHealthVaccine Coverage and HesitancyOpen Access
Read Source

Looking beyond COVID-19 vaccine phase 3 trials

Verified

Jérôme H. Kim, Florian Marks, John D Clemens

Journal: Nature MedicineYear: 2021Citations: 632

After the recent announcement of COVID-19 vaccine efficacy in clinical trials by several manufacturers for protection against severe disease, a comprehensive post-efficacy strategy for the next steps to ensure vaccination of the global population is now required. These considerations should include ...

Health SciencesMedicineInfectious Diseases
Read Source

Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks

Verified

Hossam M. Ashour, Walid F. Elkhatib, Md. Masudur Rahman, Hatem A. Elshabrawy

Journal: PathogensYear: 2020Citations: 627

Coronaviruses (CoVs) are RNA viruses that have become a major public health concern since the Severe Acute Respiratory Syndrome-CoV (SARS-CoV) outbreak in 2002. The continuous evolution of coronaviruses was further highlighted with the emergence of the Middle East Respiratory Syndrome-CoV (MERS-CoV)...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency

Verified

Thamina Acter, Nizam Uddin, Jagotamoy Das, Afroza Akhter et al.

Journal: The Science of The Total EnvironmentYear: 2020Citations: 591

According to data compiled by researchers at Johns Hopkins University in Baltimore, Maryland, more than two and half million cases of coronavirus disease 2019 (COVID-19), caused by a newly discovered virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been confirmed on Apr...

Health SciencesMedicineRadiology, Nuclear Medicine and ImagingOpen Access
Read Source

Covid-19 vaccine hesitancy among ethnic minority groups

Verified

Mohammad S Razai, Tasnime Osama, Douglas GJ McKechnie, Azeem Majeed

Journal: BMJYear: 2021Citations: 510

With mass covid-19 vaccination efforts under way in many countries, including the UK, we need to understand and redress the disparities in its uptake. Data to 14 February 2021 show that over 90% of adults in Britain have received or would be likely to accept the covid-19 vaccine if offered. 1 Howeve...

Social SciencesHealthVaccine Coverage and HesitancyOpen Access
Read Source

Immune response in COVID-19: A review

Verified

Mohammad Asaduzzaman Chowdhury, Nayem Hossain, Mohammod Abul Kashem, Md. Abdus Shahid et al.

Journal: Journal of Infection and Public HealthYear: 2020Citations: 459

The immune system protects against viruses and diseases and produces antibodies to kill pathogens. This review presents a brief overview of the immune system regarding its protection of the human body from COVID-19; illustrates the process of the immune system, how it works, and its mechanism to fig...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries

Verified

Suzanna Awang Bono, Edlaine Faria de Moura Villela, Ching Sin Siau, Won Sun Chen et al.

Journal: VaccinesYear: 2021Citations: 365

Vaccination is fast becoming a key intervention against the ongoing COVID-19 pandemic. We conducted cross-sectional online surveys to investigate COVID-19 vaccine acceptance across nine Low- and Middle-Income Countries (LMICs; N = 10,183), assuming vaccine effectiveness at 90% and 95%. The prevalenc...

Social SciencesHealthVaccine Coverage and HesitancyOpen Access
Read Source

ENDEMIC CHOLERA IN RURAL BANGLADESH, 1966–1980

Verified

Roger I. Glass, Stan Becker, M. I. Huq, Barbara J. Stoll et al.

Journal: American Journal of EpidemiologyYear: 1982Citations: 361

Since 1963, the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), formerly the Cholera Research Laboratory, has maintained a field station in Matlab to treat patients from a surveillance population of 240,000 who have cholera and other diarrheal diseases. Since 1966, the au...

Life SciencesBiochemistry, Genetics and Molecular BiologyEndocrinology
Read Source

Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic

Verified

Rekha Khandia, Shailja Singhal, Taha Alqahtani, Mohammad Amjad Kamal et al.

Journal: Environmental ResearchYear: 2022Citations: 320

Since the appearance in the late of December 2019, SARS-CoV-2 is rapidly evolving and mutating continuously, giving rise to various variants with variable degrees of infectivity and lethality. The virus that initially appeared in China later mutated several times, wreaking havoc and claiming many li...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Prevalence of Asymptomatic SARS-CoV-2 Infection

Verified

Daniel P. Oran, Eric J. Topol

Journal: Annals of Internal MedicineYear: 2021Citations: 309

LettersFebruary 2021Prevalence of Asymptomatic SARS-CoV-2 InfectionFREEDaniel P. Oran, AM, Eric J. Topol, MDDaniel P. Oran, AMScripps Research Translational Institute, Scripps Research La Jolla, CaliforniaSearch for more papers by this author, Eric J. Topol, MDScripps Research Translational Institut...

Physical SciencesMathematicsModeling and Simulation
Read Source

Myths and conspiracy theories on vaccines and COVID-19: Potential effect on global vaccine refusals

Verified

Irfan Ullah, Kiran Shafiq Khan, Muhammad Junaid Tahir, Ali Ahmed et al.

Journal: VacunasYear: 2021Citations: 301

The current coronavirus disease 2019 (COVID-19) pandemic is one of the international crises and researchers are working collaboratively to develop a safe and effective COVID-19 vaccine. The World Health Organization recognizes vaccine hesitancy as the world's top threat to public health safety, part...

Social SciencesHealthVaccine Coverage and HesitancyOpen Access
Read Source

Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity

Verified

M. Rafiul Islam, M. Nazmul Hoque, M. Shaminur Rahman, A. S. M. Rubayet Ul Alam et al.

Journal: Scientific ReportsYear: 2020Citations: 294

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel evolutionary divergent RNA virus, is responsible for the present devastating COVID-19 pandemic. To explore the genomic signatures, we comprehensively analyzed 2,492 complete and/or near-complete genome sequences of SARS-CoV-2 stra...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence

Verified

Md Arif Billah, Md. Mamun Miah, Md Nuruzzaman Khan

Journal: PLoS ONEYear: 2020Citations: 282

BACKGROUND: The coronavirus (SARS-COV-2) is now a global concern because of its higher transmission capacity and associated adverse consequences including death. The reproductive number of coronavirus provides an estimate of the possible extent of the transmission. This study aims to provide a summa...

Health SciencesMedicineObstetrics and GynecologyOpen Access
Read Source
PreviousPage 1 of 2+Next